BACKGROUND: Clinicians and patients find prognosis and end-of-life care discussions challenging. Misunderstanding one's prognosis can contribute to poor decision-making and end-of-life quality of life. A question prompt list (booklet of questions patients can ask clinicians) targeting these issues may help overcome communication barriers. None exists for end-of-life discussions outside the palliative care setting. AIM: To develop/pilot a question prompt list facilitating discussion/planning of end-of-life care for oncology patients with advanced cancer from Australia and the United States and to explore acceptability, perceived benefits/challenges of using the question prompt list, suggestions for improvements and the necessity of country-specific adaptations. DESIGN: An expert panel developed a question prompt list targeting prognosis and end-of-life issues. Australian/US semi-structured interviews and one focus group elicited feedback about the question prompt list. Transcribed data were analysed using qualitative methods. SETTING/PARTICIPANTS: Thirty-four patients with advanced cancer (15 Australian/19 US) and 13 health professionals treating such patients (7 Australian/6 US) from two Australian and one US cancer centre participated. RESULTS: Most endorsed the entire question prompt list, though a minority queried the utility/appropriateness of some questions. Analysis identified four global themes: (1) reinforcement of known benefits of question prompt lists, (2) appraisal of content and suggestions for further developments, (3) perceived benefits and challenges in using the question prompt list and (4) contrasts in Australian/US feedback. These contrasts necessitated distinct Australian/US final versions of the question prompt list. CONCLUSIONS: Participants endorsed the question prompt list as acceptable and useful. Feedback resulted in two distinct versions of the question prompt list, accommodating differences between Australian and US approaches to end-of-life discussions, highlighting the appropriateness of tailoring communication aides to individual populations.
BACKGROUND: Clinicians and patients find prognosis and end-of-life care discussions challenging. Misunderstanding one's prognosis can contribute to poor decision-making and end-of-life quality of life. A question prompt list (booklet of questions patients can ask clinicians) targeting these issues may help overcome communication barriers. None exists for end-of-life discussions outside the palliative care setting. AIM: To develop/pilot a question prompt list facilitating discussion/planning of end-of-life care for oncology patients with advanced cancer from Australia and the United States and to explore acceptability, perceived benefits/challenges of using the question prompt list, suggestions for improvements and the necessity of country-specific adaptations. DESIGN: An expert panel developed a question prompt list targeting prognosis and end-of-life issues. Australian/US semi-structured interviews and one focus group elicited feedback about the question prompt list. Transcribed data were analysed using qualitative methods. SETTING/PARTICIPANTS: Thirty-four patients with advanced cancer (15 Australian/19 US) and 13 health professionals treating such patients (7 Australian/6 US) from two Australian and one US cancer centre participated. RESULTS: Most endorsed the entire question prompt list, though a minority queried the utility/appropriateness of some questions. Analysis identified four global themes: (1) reinforcement of known benefits of question prompt lists, (2) appraisal of content and suggestions for further developments, (3) perceived benefits and challenges in using the question prompt list and (4) contrasts in Australian/US feedback. These contrasts necessitated distinct Australian/US final versions of the question prompt list. CONCLUSIONS:Participants endorsed the question prompt list as acceptable and useful. Feedback resulted in two distinct versions of the question prompt list, accommodating differences between Australian and US approaches to end-of-life discussions, highlighting the appropriateness of tailoring communication aides to individual populations.
Authors: Monica E Lemmon; Hanna E Huffstetler; Pamela Donohue; Madelaine Katz; Mary C Barks; Emma Schindler; Debra Brandon; Renee D Boss; Peter A Ubel Journal: J Child Neurol Date: 2019-05-29 Impact factor: 1.987
Authors: Paul R Duberstein; Paul K Maciejewski; Ronald M Epstein; Joshua J Fenton; Benjamin Chapman; Sally A Norton; Michael Hoerger; Marsha N Wittink; Daniel J Tancredi; Guibo Xing; Supriya Mohile; Richard L Kravitz; Holly G Prigerson Journal: J Palliat Med Date: 2019-06-25 Impact factor: 2.947
Authors: Rachel A Rodenbach; Kim Brandes; Kevin Fiscella; Richard L Kravitz; Phyllis N Butow; Adam Walczak; Paul R Duberstein; Peter Sullivan; Beth Hoh; Guibo Xing; Sandy Plumb; Ronald M Epstein Journal: J Clin Oncol Date: 2017-01-30 Impact factor: 44.544
Authors: Anita Amundsen; Bente Ervik; Phyllis Butow; Martin H N Tattersall; Svein Bergvik; Tore Sørlie; Tone Nordøy Journal: Support Care Cancer Date: 2016-08-19 Impact factor: 3.603
Authors: Rebecca E Ryan; Michael Connolly; Natalie K Bradford; Simon Henderson; Anthony Herbert; Lina Schonfeld; Jeanine Young; Josephine I Bothroyd; Amanda Henderson Journal: Cochrane Database Syst Rev Date: 2022-07-08
Authors: David J Mariano; Adam Liu; Sara L Eppler; Michael J Gardner; Serena Hu; Marc Safran; Loretta Chou; Derek F Amanatullah; Robin N Kamal Journal: Clin Orthop Relat Res Date: 2021-02-01 Impact factor: 4.755
Authors: Ronald M Epstein; Paul R Duberstein; Joshua J Fenton; Kevin Fiscella; Michael Hoerger; Daniel J Tancredi; Guibo Xing; Robert Gramling; Supriya Mohile; Peter Franks; Paul Kaesberg; Sandy Plumb; Camille S Cipri; Richard L Street; Cleveland G Shields; Anthony L Back; Phyllis Butow; Adam Walczak; Martin Tattersall; Alison Venuti; Peter Sullivan; Mark Robinson; Beth Hoh; Linda Lewis; Richard L Kravitz Journal: JAMA Oncol Date: 2017-01-01 Impact factor: 31.777
Authors: Michael Hoerger; Ronald M Epstein; Paul C Winters; Kevin Fiscella; Paul R Duberstein; Robert Gramling; Phyllis N Butow; Supriya G Mohile; Paul R Kaesberg; Wan Tang; Sandy Plumb; Adam Walczak; Anthony L Back; Daniel Tancredi; Alison Venuti; Camille Cipri; Gisela Escalera; Carol Ferro; Don Gaudion; Beth Hoh; Blair Leatherwood; Linda Lewis; Mark Robinson; Peter Sullivan; Richard L Kravitz Journal: BMC Cancer Date: 2013-04-09 Impact factor: 4.430
Authors: Adam Walczak; Phyllis N Butow; Josephine M Clayton; Martin H N Tattersall; Patricia M Davidson; Jane Young; Ronald M Epstein Journal: BMJ Open Date: 2014-06-26 Impact factor: 2.692